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Abstract 
Background: Physiotherapists play a fundamental role in managing adults with hypermobility 
and hypermobility syndrome (HMS). Access to training and its influence on the physiotherapy 
treatment of hypermobile adults is unknown.  
Objectives: The purpose of this study was to: 
i) Explore UK physiotherapists’ knowledge of hypermobility and HMS in adults. 
ii) Establish the relationship between knowledge and training or experience. 
iii) Investigate the future training preferences of physiotherapists in this area. 
Design: A nationwide online survey 
Methods: A cross-sectional survey design collected quantitative and qualitative data. A 
validated hypermobility questionnaire was adapted and distributed as a self - administered 
electronic survey. A panel of expert practitioners confirmed face validity.  
Participants: UK physiotherapists, experienced in treating adults with musculoskeletal 
conditions were invited to participate via purposive and snowball sampling of relevant 
professional networks and clinical interest groups. 
Analysis: Microsoft Excel and SPSS were used to analyse data. Chi-squared analysis was 
used to explore relevant associations. Thematic coding of qualitative data was quantitatively 
analysed. 
Results: 244 Physiotherapists participated. A significant association was found between 
training and knowledge of HMS (P<0.001). Furthermore, training was associated with 
increased clinical confidence in both assessment (P<0.001), and management (P<0.001) of 
the condition. However, 51% of physiotherapists reported having no training in hypermobility, 
only 10% had undergone training in hypermobility at undergraduate level and 95% requested 
further training. 
Conclusion: There are significant gaps in training received by UK physiotherapists’ in the 
assessment and management of HMS, despite the significant association observed between 
training and the degree of clinical confidence and knowledge reported. 
(Word count = 248 excluding title including headings)  
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Introduction 
 
A joint is considered hypermobile when, taking age, gender and ethnicity into account, it 
moves excessively beyond its expected range [1]. Joint hypermobility can occur in an isolated 
area but is often widespread. This generalised hypermobility (GH) does not necessarily cause 
symptoms and can be an asset, allowing individuals to excel in sports or the performing arts 
[2]. Distinction should be made between GH and Hypermobility Syndrome (HMS), where 
underlying fragility of connective tissue is thought to be responsible for an array of symptoms 
[1]. In addition to inherited forms of hypermobility, joints can also acquire hypermobility for 
example, as a result of training or habitual postures [3].  
 
GH is thought to affect 10-30% of the population, is more common in females, and decreases 
with aging [4]. Incidence is considered highest amongst Asian, then African populations, and 
lowest amongst Caucasians. Incidence seems higher in clinical populations. An observational 
study of new patients attending a Primary Care musculoskeletal triage clinic in London 
(n=150) used the Beighton Score and the Brighton Criteria to screen for GH and HMS 
respectively. The researchers demonstrated GH in 19% (Beighton score of 4 or more) and 
HMS in 30% of attendees [5]. In another study of patients attending a North London 
rheumatology clinic, incidence of HMS was 30% amongst males (Caucasian and non-
Caucasian) and Caucasian females. The incidence doubled to 60% amongst non-Caucasian 
females [6]. 
 
HMS is an inherited connective tissue disorder, sharing phenotypic features with other 
connective tissue disorders such as Ehlers-Danlos Syndrome (EDS), Osteogenesis 
Imperfecta and Marfan’s Syndrome [7]. Currently, HMS is believed to result from an 
undetermined genetic abnormality of matrix proteins and collagen within connective tissues, 
which results in excessive joint range of movement, tissue laxity and fragility [8]. Until recently 
HMS was known as benign joint hypermobility syndrome [7]. This potentially understated the 
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serious consequences of chronic pain and disability associated with the condition. As joint 
hypermobility syndrome is often considered indistinguishable from EDS hypermobility type 
[9], combining the two conditions under a diagnostic umbrella may enhance recognition and 
management [10]. There is ongoing debate over name and classification in the literature. To 
avoid confusion, HMS will be used as an umbrella term for these two conditions in this paper. 
 
HMS is increasingly recognised as a multi-systemic condition, with musculoskeletal and non-
articular features. Widespread pain is common, resulting from tissue strain, dislocations or 
surgery [11]. Analgesia, anxiety and perceived impairment in HMS all have the potential to 
contribute to processing changes within the central nervous system [12]. Resultant chronic 
pain and kinesiophobia can lead to deconditioning and a debilitating loss of function [13]. 
Reduced proprioceptive acuity, particularly in lower limb joints is recognised in HMS [14]. 
Lack of kinaesthetic awareness and consequent adoption of unfavourable biomechanical 
positions, may further exacerbate pain [15]. 
 
Muscle weakness and fatigue are common features of HMS and often coexist, but their 
causes and relationship is not fully understood [16]. Rombaut et al. [17] demonstrated 
reduced muscle strength, strength/endurance and lower limb function in Caucasian females 
with HMS compared with age matched controls. Causes of muscle weakness found in HMS 
may be biomechanical failure of the extracellular matrix [18], or neuromuscular deficit [19]. 
Inefficient muscle action may contribute to excessive fatigue, or there may be systemic 
explanations perhaps linked with autonomic dysfunction [20], pain, or psychological distress, 
[16]. Furthermore, Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM) are conditions 
with overlapping features of sleep impairment, fatigue and musculoskeletal pains [21].  
Sub-groups of both conditions have been described with higher incidence of joint 
hypermobility than in the general population [22]. 
 
Associated non-articular features of HMS have been reported. Tissue laxity potentially results 
in incontinence [10], asthma [23] and gastrointestinal tract dysfunction [24]. 
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Neurophysiological traits include resistance to anaesthetics [25] and cardiovascular 
autonomic disturbances including orthostatic intolerance, and postural tachycardia syndrome 
[20]. These dysautonomias may be a primary cause of physical deconditioning or present as 
a secondary effect of reduced fitness [20]. Furthermore, individuals with HMS demonstrate a 
considerable increased risk of developing panic disorders, agoraphobia and social anxiety. A 
fifteen year follow-up cohort study found anxiety was twenty two times more likely amongst 
HMS subjects with associated use of anxiolytic drugs compared with non-hypermobile 
individuals [26].  
 
Management of adults with HMS is complex and often involves multidisciplinary collaboration 
with physiotherapists playing a fundamental role within this team [7]. However, there is little 
robust evidence supporting optimum physiotherapy strategies, and a lack of clinical 
guidelines for the assessment and management of this multi-systemic condition. Therefore it 
is of interest to explore current physiotherapy knowledge and practice as this may help guide 
future research. This research builds on previous work undertaken in 2008, [27] in which 
Deane et al. designed the Hypermobility and HMS questionnaire (HHQ) to examine the 
baseline perceptions amongst adult musculoskeletal physiotherapists within three of the 
largest NHS teaching hospitals in London. Findings were that both knowledge of symptoms 
and the adoption of appropriate management strategies for HMS were significantly related to 
whether the physiotherapist had received training about the condition (P=0.05). However, 
88% of those surveyed had received no undergraduate, and 60% had received no 
postgraduate training in HMS. A recent nationwide survey of paediatric physiotherapists 
(n=91) found 51% had received no training in hypermobility, [28]. The purpose of this study 
was therefore to investigate these themes at national level with the objectives to: 
 
i) Explore UK physiotherapists’ knowledge of hypermobility and HMS in adults. 
ii) Establish the relationship between knowledge and training or experience. 
iii) Investigate the future training preferences of physiotherapists in this area. 
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Method 
Research design  
A cross-sectional electronic survey was used to investigate views of musculoskeletal 
physiotherapists working within the UK.  
 
Ethical approval was granted by the University of Hertfordshire (Ethics Committee with 
Delegated Authority for Health and Human Sciences).   
 
A literature search was performed (March – June 2013) using Cinahl, Pubmed and the 
Cochrane databases as these were predicted to include relevant physiotherapy, 
rheumatology and medical literature related to the topic. A previously validated questionnaire, 
the HHQ [27] was revised to include demographic questions and expand the associated 
features and management options sections to reflect current HMS literature. A pilot study was 
completed to ensure face validity of the adapted instrument. Eight expert physiotherapists 
were invited to participate in the pilot. Expertise was defined as specialised clinical 
experience with this client group, publication or lecturing in the field of hypermobility. Minor 
modifications were made as a result of the pilot. The revised tool was named the Modified 
Hypermobility and Hypermobility Syndrome Questionnaire (Modified HHQ) and can be found 
in Appendix 1. 
The survey was converted to an electronic format using Bristol Online Survey software. 
Questions were generally closed, generating quantitative data. Qualitative data was collected 
through six open-ended questions to add depth and provide insight into clinician’s responses. 
Informed consent was gained on the initial page of the survey. Questions were mandatory, 
which avoided the collection of incomplete data. The exception was a question seeking views 
regarding treatment effectiveness. Respondents could omit this question if they felt unable to 
comment due to lack of experience in treating the condition. 
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Data collection  
Purposive distribution targeted physiotherapists who treat adults within a musculoskeletal 
setting in the UK. Relevant permissions were sought allowing the questionnaire to be 
distributed via the iCSP, Allied Health Professions Research Network (AHPRN) and a variety 
of professional special interest groups who either posted it onto their websites or emailed it to 
their members.  
 
Snowball sampling, a chain referral recruiting mechanism [29], boosted responses. Interested 
participants were asked to snowball the survey to other potential participants within their 
network. Pre-notification and reminders were used to enhance response rate [30]. The survey 
was open for six weeks between September 11th and 23rd October 2013. 
  
Data analysis 
Data was transferred from Bristol Online software to Microsoft Excel. Correct answers were 
given a point with other responses scoring zero. Descriptive statistics were used to compare 
knowledge scores. Data about knowledge, training, experience, assessment confidence and 
management confidence was assigned to categories and coded as high or low. Chi square 
analysis (IBM SSPS Statistics 21 software) was used to explore relevant associations 
between categories and establish significance levels.  
 
Inductive content analysis was used to evaluate the qualitative data. Themes were 
established from the data and coded. Similar responses were assigned to broad categories in 
order to interpret and describe the information collected. 
 
Results 
Demographics 
244 complete questionnaires were returned with all UK regions represented as demonstrated 
in Figure 1. Insert Figure 1 here. 
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The majority of questionnaires, 75% (182/244), were completed by physiotherapists working 
in musculoskeletal outpatients, where 48% (116/244) reported working in the NHS and 27% 
(66/244) in the private sector. Representation from other clinical specialities included: 
Rheumatology (9%), Women’s Health (3%), Orthopaedics (2%), Sports (2%) and Performing 
Arts (1%). The remainder were non-specific clinical areas such those working in rotational 
posts. 
 
Training in hypermobility 
The majority, 94% (230/244), of respondents reported having trained as a physiotherapist in 
the UK; 6% (14/244) had trained overseas. Half of the respondents, 51% (124/244), had 
received no specific training in hypermobility. Only 10% (24/244) reported having received 
hypermobility training as an undergraduate, and this was highest amongst therapists who had 
qualified within the last five years. Most experienced therapists had undertaken hypermobility 
training as a postgraduate. 
 
Experience 
85% (209/244) of respondents reported more than 5 years of clinical experience. A summary 
of postgraduate experience is presented in Table 1. Insert Table 1 here. 
 
Knowledge 
Knowledge of three broad areas was considered: general epidemiological factors, 
musculoskeletal and non-articular features, which were added to provide a total knowledge 
score with a maximum value of 32. Respondents were considered to have limited knowledge 
if they scored <17/32 and good knowledge if they scored ≥17/32. The mean score was 
6.86/11 (sd = 1.85) for epidemiological factors, 6.65/9 (sd = 1.47) for musculoskeletal features 
and 6.42/12 (sd = 3.29) for non-articular features. A summary of knowledge scores is found in 
Table 2. Insert Table 2 here. 
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Analysis 
Chi square analysis was used to establish the relationship between knowledge and training, 
experience and confidence. A significant association was found between both knowledge 
(total score) and hypermobility training, [ (1) = 14.432, P<0.001] and also between 
knowledge and years of postgraduate experience [ (1) = 8.444, P<0.004]. Furthermore, 
practitioners who had received training in hypermobility (P<0.001) reported significantly 
increased confidence in both assessment [ (1) = 27.472, P<0.001] and management, [ (1) 
= 14.747, P<0.001] of HMS.  
 
 Future Learning 
Therapists were asked about preferences for training and could indicate multiple choices.  
95% (231/244) indicated an interest in pursuing training in hypermobility, requesting a range 
of learning materials (Figure 2). Publications, courses and CPD workshops were the main 
preferences. Insert figure 2 here. 
 
Discussion 
A survey was conducted to gain insight into current knowledge of hypermobility and HMS 
amongst UK physiotherapists working with adults and to explore any relationship between 
their experience and any training they had received. A total of 244 completed surveys were 
returned, with representation from all UK regions. Most respondents, 85% (209/244), reported 
greater than five years’ experience, similar to 84% in a study of paediatric physiotherapists 
[28]. This may reflect the sampling methods and distribution networks used. Alternatively, it 
may be that this complex condition is encountered or clinically recognised more often by 
experienced practitioners.  
 
Knowledge – General 
Physiotherapists generally knew most about the musculoskeletal features of HMS and least 
about the non-articular features. Knowledge of general epidemiological features of HMS was 
mixed. Most respondents, 89% (217/244), knew that it is a heritable condition, 94% (230/244) 
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that it affects ligaments, and 91% (222/244) that it is more common in females. Knowledge of 
prevalence in the general population was poor, 54% (132/244). Agreement of the ethnic 
dominance of hypermobility in Asian populations was low, 33% (81/244). Variations linked to 
ethnicity are complex [4].  
 
Although GH can be an asset [2], it has also been suggested in the literature that it may 
predispose to injury, not only in sport [31] and the performing arts [32], but also amongst 
musculoskeletal caseloads [5,6], and therefore recognition by clinicians is important. 
Increased awareness may enable better screening for hypermobility during selection or 
assessment. Fewer than half of respondents, 48% (116/244) recognised that hypermobility 
could be acquired. This can occur through training, stretching or habitual end range postures. 
Recognition may help to protect vulnerable joints from acquiring hypermobility when the wider 
kinetic chain is considered during training or rehabilitation. 
 
The ability to distinguish between GH and HMS was also limited. Despite 57% (139/244) of 
responses indicating there is a difference, only 28% (68/244) gave a correct definition of 
HMS. A common misunderstanding was that a high Beighton score determined a diagnosis of 
HMS. The Beighton score, although originally designed for epidemiological purposes, has 
been widely adopted as an assessment tool for GH. The tool has limitations with lack of 
consensus about the diagnostic cut-off point leading to confusion over diagnosis [4]. 
Furthermore, evaluation is restricted to specified joints and the severity of hypermobility is not 
measured. As the Beighton score fails to evaluate the associated features of HMS, the 
revised Brighton scoring system is the recommended alternative [7]. Training is required here. 
The multi-systemic presentation of HMS must be recognised by clinicians in order to tailor 
treatment appropriately and collaborate with multidisciplinary colleagues when required.  
 
Knowledge – Musculoskeletal 
Knowledge scores were higher for all musculoskeletal features than in an earlier study [27]. 
Many practitioners included within the sample were highly experienced in musculoskeletal 
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physiotherapy, which may account for the greater knowledge seen in this study, or it could 
reflect increased awareness of hypermobility through recent publications and training.  
 
Knowledge – Associated conditions 
56% (137/244) of respondents felt osteoarthritis was associated with HMS. Whether 
hypermobility predisposes towards osteoarthritis [33], or protects against it [34] remains 
unknown [4]. Further research to establish the relationship was recently recommended in a 
comprehensive systematic review of osteoarthritis [35].  
 
The impact of CFS and FM was explored. Only 39% (96/244) of respondents thought HMS 
was related to CFS and 50% (123/244) thought it was related to FM. Literature supports 
association of these conditions [21, 22]. Voermans et al. [16] suggest that more than three-
quarters of individuals with HMS suffer from disabling fatigue, which is also often associated 
with poor concentration, sleep impairment and impaired social functioning. Recognition of the 
overlap between these syndromes may need to be highlighted in education programmes. 
Future collaborative research is recommended. 
 
Knowledge – Non-articular features 
Respondents were least knowledgeable about non-articular features. Poor recognition of 
delayed healing in HMS, 48% (118/244) has an impact on expected response to treatment 
and duration of physiotherapeutic intervention [31]. Only 11% (26/244) of therapists were 
aware of the association with asthma [23], which has implications for rehabilitation. 
 
The relationship between the physical, autonomic and psychological features of HMS in 
acting as drivers for the condition is of interest [26]. Dysautonomia has been cited as a cause 
for the anxiety features which are over-represented in HMS individuals [36].  Although well 
documented [20], fewer than half, 45% (109/244), of respondents recognised the association 
between dysautonomias and HMS. Further research and awareness is necessary. 
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Effect of training and experience 
Half the respondents, 51% (124/244) reported that they had not had any training in 
hypermobility. A significant association was found between knowledge of HMS and both 
training (P<0.001) and experience (P<0.004). Furthermore, confidence of assessment and 
management of HMS was significantly higher where those therapists had better knowledge  
(P<0.001) or had received training (P<0.001). Confidence relating to assessment and 
management practices was not found to be associated with experience (P=0.61 and P = 0.48 
respectively). Only 10% (24/244) of respondents had received training in hypermobility as 
undergraduates.  
 
Future education and research 
Findings from this study support the need for hypermobility training for UK physiotherapists. 
The majority, 95% (231/244), of respondents were interested in pursuing further training in 
HMS. Books, journals, courses and CPD workshops were the preferred learning methods 
chosen by respondents. This may reflect individual circumstances or learning styles. As 
autonomous practitioners, physiotherapists strive to apply knowledge to clinical decision 
making as part of a reasoning process [37]. Lack of accessible knowledge can be a limiting 
factor in proficient clinical reasoning [38]. 
 
Qualitative research investigating experiences of physiotherapists working in the NHS [39] 
concluded that undertaking CPD improves confidence as well as competence, enabling 
individuals to form effective therapeutic relationships with patients and other members of their 
teams. In other research, Petty and colleagues [40] considered the impact on physiotherapy 
graduates of undertaking Musculoskeletal MSc programmes in the UK. They identified three 
key impact domains, critical understanding of practice knowledge, patient centered practice 
and capability to learn in, and from, clinical practice. The most powerful experience to trigger 
practice change was direct observation and feedback of clinical practice by educators.  
The future of education in the area of hypermobility may require a combination of existing and 
alternative methods. This could include observational learning, and the formation of focus or 
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clinical interest groups. These kinds of collaborative working where professionals share their 
knowledge and experiences can enhance clinical practice and outcomes [41, 42].  
 
Limitations of the study 
Several limitations have been identified. Although test / retest reliability was high for the 
original questionnaire, the extent to which this was transferred to the electronic version was 
not tested and therefore remains unknown. 
 
Sampling errors arose from the selection process. A recognised flaw of volunteer sampling is 
the inability to accurately calculate the sample frame and non-response bias [43]. The 
snowball sampling technique can result in over-representation of certain characteristics [29] 
and the networks used may have led to a sample biased towards experienced practitioners.  
 
Best practice recommends controlling survey admission by password in order to guarantee 
inclusion criteria and prevent multiple entries. A limitation of the software used was the 
inability to check if participants had made more than one submission or met the inclusion 
criteria. The latter was assumed as participants were targeted through professional interest 
groups with controlled memberships. 
 
Statistical testing was used to compare knowledge and training. Assumptions were made in 
order to perform the tests. Knowledge was considered high if participants scored 50-100%, 
which is an arbitrary figure. Similarly, therapists were considered experienced if they had 
more than five years’ experience, the justification being that physiotherapists commonly 
specialise in a field of practice at around that time. Consequently there was a disparity in the 
sample size used for comparison of experience, which undoubtedly caused bias.  
 
Conclusions 
Physiotherapy caseloads are likely to include GH and HMS, both of which present frequently 
within adult clinical services. 
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 Hypermobility and HMS training is not widely available to UK physiotherapists. 
 This study indicates that training is significantly related to clinical confidence and 
knowledge. 
 Recognition of the non-articular features of HMS is a priority for educational 
programmes.  
 UK physiotherapists request publications, courses and CPD workshops about 
hypermobility. 
 Further research is needed to help inform clinical practice. 
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Figure 1: Graph of geographical distribution of respondents 
 
 
 
 
 
 Clinical experience 
0-2 years 3-5 years 6-9 years 10-15 years >15 years 
Number of 
responses 
12 23 35 63 111 
Percentage 
response 
5% 9% 14% 26% 45% 
Table 1: Breakdown of respondents’ postgraduate clinical experience 
 
 
 
 
Knowledge of: 
 
n Minimum 
Score 
Maximum 
Score 
Range 
Of 
Scores 
Mean 
Score 
Standard 
deviation 
Epidemiology  
Score out of 11 
244 2 11 9 6.86 1.85 
 
 
Musculoskeletal 
features 
Score out of 9 
244 1 9 8 6.65 1.47 
Non articular 
features 
Score out of 12 
244 0 12 12 6.42 3.29 
 
 
Table 2. Participants’ knowledge of the various aspects of HMS 
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Figure 2: Respondents’ preferences for future learning about HMS 
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Appendix 1 
The Modified HHQ 
 (Based on “Questionnaire: Hypermobility and Hypermobility Syndrome” by Deane, Keer & Simmonds 2008) 
 
DEMOGRAPHICS 
Which region are you currently working in? ☐E England 
☐East Midlands 
☐Ireland 
☐London 
☐NE England  
 
☐NW England 
☐SC England 
☐Scotland 
☐SE England 
☐SW England 
 
☐Wales 
☐W Midlands 
☐Yorks/ 
Humber 
How did you hear about this questionnaire? ☐ ACPIHC ☐ APPI 
 
☐ MACP 
 ☐ ACPWH 
☐ AHP 
research hub  
 
☐ From 
Colleague 
☐ i CSP 
 
☐ PPA 
☐   Other 
 
In which clinical area do you predominantly work? ☐MSK OP (NHS) 
☐MSK OP 
(Private) 
☐Orthopaedics 
 
☐Performing      
arts 
☐Rheumatolog
y 
 
☐Sports 
☐Women’s 
Health 
☐Other 
TRAINING AND EDUCATION 
In which country did you graduate? ☐ UK Other (please specify) 
    
How many years of postgraduate clinical experience 
do you have? 
☐ 0-2 years 
☐ 3-5 years 
☐ 6-9 years 
☐10-15 years 
☐ >15 years 
    
Have you had any undergraduate training in 
(hypermobility syndrome) HMS? 
☐ Yes  ☐ No 
    
Have you had any postgraduate training in HMS? ☐ Yes  ☐ No 
    
Are there any specialised hypermobility resources / 
facilities at your workplace? 
☐ Yes (please specify) ☐ No 
HYPERMOBILITY AND HYPERMOBILITY SYNDROME 
How prevalent is hypermobility in the general 
population? 
☐ 0 – 10% 
☐ 10-30% 
☐ 30-50% 
☐ >50% 
☐ Unsure 
    
Could hypermobility be inherited? ☐ Yes ☐ No ☐ Unsure 
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Could hypermobility be acquired? ☐ Yes ☐ No ☐ Unsure 
    
Is hypermobility more prevalent in males or females? ☐ Males ☐ Females ☐ Unsure 
    
In which ethnic group is hypermobility most common? ☐ African  
☐ Unsure 
☐ Asian ☐ Caucasian 
    
Is there a difference between hypermobility and HMS? ☐ Yes ☐ No ☐ Unsure 
What is the difference?    
Which tissue does hypermobility primarily affect?  
(Tick one) 
☐ Muscle 
☐ Bone 
☐ Ligaments 
☐ Nerves 
☐ Skin 
☐ Unsure 
    
ASSESSMENT 
Are you confident in your assessment of hypermobility 
and HMS patients? 
☐ Yes ☐ No  
    
Do you use any of the following tools when assessing individuals with hypermobility and HMS? 
Beighton Score ☐ Yes ☐ No ☐Never heard of it 
Brighton Criteria ☐ Yes ☐ No ☐Never heard of it 
Self – report (simple) questionnaire ☐ Yes ☐ No ☐Never heard of it 
☐ Other (please specify) 
 
 
 
ASSOCIATED FEATURES 
Which of the following features do you associate with HMS? 
 
MUSCULOSKELETAL FEATURES 
 
Chronic pain ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Dislocation / subluxation ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Fibromyalgia ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Laxity ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Osteoarthritis ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Paraesthesia ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Proprioceptive deficit ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Rheumatoid arthritis ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Weakness 
 
 
☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
EXTRA ARTICULAR FEATURES 
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Altered response to anaesthetic ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Anxiety ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Asthma ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Diabetes ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Delayed wound healing ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Eczema ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Fatigue ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Gastrointestinal dysfunction ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Postural tachycardia syndrome (PoTS) ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Prolapse (mitral valve, uterine, rectal) ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Striae ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Urinary incontinence ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
 
RELATED CONDITIONS  
 Is hypermobility related to any of the following? 
 
 
Heritable disorders of connective tissue 
including Ehlers’ Danlos Syndrome, Marfan’s 
Syndrome, Osteogenesis Imperfecta? 
 
☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
Pregnancy? ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
 
Chronic Fatigue Syndrome? ☐ Yes ☐ No ☐ Unsure ☐ Never heard of it 
     
 
MANAGEMENT 
 
Are you confident in your 
management of HMS? 
 
☐ Yes 
  
☐ No 
 
     
 
Does a diagnosis of HMS affect your 
management approach? 
 
☐ Yes 
  
☐ No 
Please comment     
 
 
How do you feel adults with HMS are 
managed best? 
 
☐ 1:1 
  
☐ In a group 
 
☐ No difference         
between these options 
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If you have treated adults with HMS which modalities have you used and how effective were they? 
 
     
Acupuncture ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Breathing exercises ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Closed chain kinetic exercise ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Cognitive behavioural approach ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Core stability training ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Education ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Electrotherapy ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Hydrotherapy ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Intensive inpatient therapy ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Manual therapy ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Pelvic floor retraining ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Proprioceptive training ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Reassurance ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Splinting / bracing ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Taping ☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Yoga 
 
☐Effective ☐Not very 
effective 
☐Ineffective ☐Do not use 
Other (please specify) 
 
 
How do you rate the impact of HMS 
on quality of life? 
 
☐Serious     ☐Significant     ☐Minimal     ☐None     ☐Unsure 
     
FUTURE LEARNING 
Are you keen to learn more about 
assessment and management of 
adults with HMS? 
☐ Yes ☐ No 
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How would you best like to learn? ☐ Books / Journals 
☐Courses 
☐CPD Workshops 
☐iCSP 
 
☐ Seminars 
☐ Webinar (online seminar) 
☐ Other (please specify) 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
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